Giuseppe Viale

8PUBLICATIONS
111CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2026
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

|Jan 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Stephen J Luen, Lauren C Brown, Courtney T van Geelen

|Sep 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

|Sep 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.

Sibylle Loibl, Jacek Jassem, Amir Sonnenblick

|Oct 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research.

Fabio Conforti, Laura Pala, Tommaso De Pas

|Sep 28, 2023
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.

Mariia Ivanova, Francesca Maria Porta, Marianna D'Ercole

Pageof 2

Frequent Collaborators

5 joint publications

Marco Colleoni

4 joint publications

Martine Piccart

3 joint publications

Richard D Gelber

2 joint publications

Chiun-Sheng Huang